POSTERS tertiary referral center, the Center of Hearing Impairment at UNIFESP.
Conclusion:
Results indicate that there is an excessive delay between the onset of the hearing difficulty and an access to specialized care. Age-related hearing loss deserves special attention from public and private health systems for its high incidence, and a significant number of patients who need and would benefit from hearing rehabilitation through electronic aids, especially hearing aids. The high prevalence of comorbidities, particularly hypertension, suggests that these diseases may play an important role in the manifestation and evolution of sensorineural hearing loss.
Otology/Neurotology Epidemiology and Complications of acoustic Neuroma Excision
Hossein Mahboubi, MD (presenter); Omar Ahmed; Sepehr Oliaei; Saman Kiumehr; Hamid R. Djalilian, MD Objective: 1) To examine surgical outcomes, charges, and demographics information for patients who have undergone an acoustic neuroma excision. 2) To determine if outcome measures and charges are significantly different between high-volume and low-volume centers.
Method: Case data for acoustic neuroma excisions performed in California from 2008 to 2010 were examined using California Hospital Discharge Data (CHDD). Cases were identified if they contained the principal procedure ICD-9-CM code 04.01. Postoperative complications were identified if cases contained ICD-9-CM codes for specific diagnoses and procedures (ie, meningitis, ventriculostomy, etc).
Results: There were 1158 cases. Most patients were between the ages of 35 and 64 years (72.8%), women (54%), and white (76.0%). The median total charge was $103,485, the average hospital stay was 5.1 days, 90.3% of patients were discharged routinely (ie, home), and 7.3% of patients endured postoperative complications. High-volume centers (10 ≤ surgeries per year average) had less complications (5.7% of patients had complication(s) vs 13%; P < .001), shorter hospital stays (4.7 days vs 6.6 days; P < .001), higher rates of routine discharges (94.8% vs 73.6%; P < .001), and lower average charges per day and total charges (P < .001).
Conclusion: Compared with lower volume centers, high-volume centers had fewer complications, shorter hospital stays, higher rates of routine discharges, and lower total charges for all services rendered and average charges per day. Interestingly, CHDD demonstrates that median total charges have risen dramatically from data reported in 1996 to 1998 ($103,485 vs $26,862) .
Otology/Neurotology Epithelial Proliferation in Cholesteatoma
Suresh C. Sharma, MBBS (presenter); Kapil Sikka; Alok Thakar, MS; S. Dattagupta Objective: Comparison of the proliferative potential of pediatric cholesteatoma with that of adult cholesteatoma, using Ki-67 as a proliferation marker.
Method: Prospective study on 67 patients with aural cholesteatoma from 2003 to 2005. Thirty-eight adult and 29 pediatric cases were evaluated using clinical parameters, including bone erosion, complications, and extent of disease. Histological evaluation of cholesteatoma and measurement of the proliferation index using Ki-67 labeling was performed. Normal skin specimen from a control group was also examined.
Results: Final assessment could be performed in 28 adult and 25 pediatric cholesteatoma cases and 12 controls. The mean Ki-67 labeling index of cholesteatoma cases was 29.2 out of 200 (14.6%). The mean index for controls was 19 out of 200 (9.5%), significantly lower than cholesteatoma group (P = .033). The mean Ki-67 labeling index was 33.5 per 200 in pediatric cases and 26.5 per 200 in adult cases. Though proliferation index was higher in pediatric cases, difference was insignificant (P = .13). Pediatric cholesteatoma was also similar to adult cholesteatoma in terms of complications, bone erosion, and disease spread.
Conclusion:
Cholesteatoma is a disorder of epithelial proliferation. Although postulated to be more aggressive in children than adults, this study found no pathological differences between pediatric and adult cases.
